Why prior authorization is different
Prior authorization AI sits between clinical documentation, payer policy, patient access, and revenue cycle operations. That makes it more sensitive than a simple queue automation tool. A buyer needs to know whether the product drafts submissions, gathers documentation, predicts requirements, automates status checks, or supports utilization management decisions.
HealthAIdir examples include Cohere Health, Availity, Waystar, and Experian Health.
What to measure
A practical pilot should measure authorization turnaround, staff touches per case, missing-documentation rate, payer response time, appeal rate, and patient scheduling delays. If a vendor claims policy intelligence, ask how rules are sourced, updated, reviewed, and audited.
Also define the human review boundary. AI may help prepare packets, identify documentation gaps, or route work, but organizations should be careful about tools that imply automated clinical determinations without clear governance.
Interoperability context
The CMS Interoperability and Prior Authorization Final Rule is important context because it emphasizes APIs and access to interoperable data for covered payers. Even when a vendor is not directly subject to a rule, buyers should expect clearer API strategies, documentation, and payer workflow support over time.
For provider organizations, the procurement question is simple: will the tool reduce avoidable administrative burden without weakening documentation quality, patient communication, or compliance review?
Source notes
Use HealthAIdir references for prior authorization, RCM, and EHR integration. CMS publishes official information on the CMS Interoperability and Prior Authorization Final Rule.